Advertisement

Acetazolamide-Responsive Episodic Ataxia Linked to Novel Splice Site Variant in FGF14 Gene

  • M. Schesny
  • F. Joncourt
  • Alexander A. TarnutzerEmail author
Short Report
  • 24 Downloads

Abstract

Here we describe the case of a patient with episodic dizziness and gait imbalance for 7 years and a negative family history. On clinical examination, interictally, the patient presented with gaze-evoked nystagmus and rebound nystagmus and slight dysarthria. MRI of the brain was normal and peripheral-vestibular function was bilaterally intact. Based on genetic testing (episodic ataxia panel), a heterozygote splice site variant in intron 1 of the FGF14 gene was identified. This report adds important new evidence to previous observations that pathogenic variants in the FGF14 gene may result in variable phenotypes, either in progressive spinocerebellar ataxia (type 27) or in episodic ataxia as in our case. Our patient responded well to acetazolamide (reduction in the frequency of attacks by about two thirds), supporting the hypothesis of a sodium channelopathy.

Keywords

Hereditary ataxia Channelopathy Cerebellum Drug treatment Haploinsufficiency 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

The final version of this manuscript has been seen by the patient and written informed consent for publication has been retrieved from the patient.

References

  1. 1.
    Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, Baloh RW, et al. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain. 2007;130:2484–93.  https://doi.org/10.1093/brain/awm126.CrossRefPubMedGoogle Scholar
  2. 2.
    Choi KD, Choi JH. Episodic Ataxias: Clinical and genetic features. J Mov Disord. 2016;9:129–35.  https://doi.org/10.14802/jmd.16028.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    McGovern EM, Roze E, Counihan TJ. The expanding spectrum of paroxysmal movement disorders: update from clinical features to therapeutics. Curr Opin Neurol. 2018;31:491–7.  https://doi.org/10.1097/WCO.0000000000000576.CrossRefPubMedGoogle Scholar
  4. 4.
    Brusse E, de Koning I, Maat-Kievit A, Oostra BA, Heutink P, van Swieten JC. Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): a new phenotype. Mov Disord. 2006;21:396–401.  https://doi.org/10.1002/mds.20708.CrossRefPubMedGoogle Scholar
  5. 5.
    Misceo D, Fannemel M, Baroy T, Roberto R, Tvedt B, Jaeger T, et al. SCA27 caused by a chromosome translocation: further delineation of the phenotype. Neurogenetics. 2009;10:371–4.  https://doi.org/10.1007/s10048-009-0197-x.CrossRefPubMedGoogle Scholar
  6. 6.
    Feil K, Claassen J, Bardins S, Teufel J, Krafczyk S, Schneider E, et al. Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial. Neurology. 2013;81:1152–8.  https://doi.org/10.1212/WNL.0b013e3182a55f6d.CrossRefPubMedGoogle Scholar
  7. 7.
    Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.  https://doi.org/10.1038/gim.2015.30.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Groth CL, Berman BD. Spinocerebellar Ataxia 27: a review and characterization of an evolving phenotype. Tremor Other Hyperkinet Mov (N Y). 2018;8:534.  https://doi.org/10.7916/D80S0ZJQ.Google Scholar
  9. 9.
    van Swieten JC, Brusse E, de Graaf BM, Krieger E, van de Graaf R, de Koning I, et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. Am J Hum Genet. 2003;72:191–9.CrossRefGoogle Scholar
  10. 10.
    Choquet K, La Piana R, Brais B. A novel frameshift mutation in FGF14 causes an autosomal dominant episodic ataxia. Neurogenetics. 2015;16:233–6.  https://doi.org/10.1007/s10048-014-0436-7.CrossRefPubMedGoogle Scholar
  11. 11.
    Coebergh JA, Fransen van de Putte DE, Snoeck IN, Ruivenkamp C, van Haeringen A, Smit LM. A new variable phenotype in spinocerebellar ataxia 27 (SCA 27) caused by a deletion in the FGF14 gene. Eur J Paediatr Neurol. 2014;18:413–5.  https://doi.org/10.1016/j.ejpn.2013.10.006.CrossRefPubMedGoogle Scholar
  12. 12.
    Amado A, Blanco MO, Reparaz-Andrade A. Spinocerebellar Ataxia 27: clinical phenotype of twin sisters with FGF14 deletion. Neuropediatrics. 2017;48:131.  https://doi.org/10.1055/s-0037-1598110.CrossRefPubMedGoogle Scholar
  13. 13.
    Choi KD, Kim JS, Kim HJ, Jung I, Jeong SH, Lee SH, et al. Genetic variants associated with episodic Ataxia in Korea. Sci Rep. 2017;7:13855.  https://doi.org/10.1038/s41598-017-14254-7.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Shimojima K, Okumura A, Natsume J, Aiba K, Kurahashi H, Kubota T, et al. Spinocerebellar ataxias type 27 derived from a disruption of the fibroblast growth factor 14 gene with mimicking phenotype of paroxysmal non-kinesigenic dyskinesia. Brain and Development. 2012;34:230–3.  https://doi.org/10.1016/j.braindev.2011.04.014.CrossRefPubMedGoogle Scholar
  15. 15.
    Dalski A, Atici J, Kreuz FR, Hellenbroich Y, Schwinger E, Zuhlke C. Mutation analysis in the fibroblast growth factor 14 gene: frameshift mutation and polymorphisms in patients with inherited ataxias. Eur J Hum Genet. 2005;13:118–20.  https://doi.org/10.1038/sj.ejhg.5201286.CrossRefPubMedGoogle Scholar
  16. 16.
    Coutelier M, Coarelli G, Monin ML, Konop J, Davoine CS, Tesson C, et al. A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies. Brain. 2017;140:1579–94.  https://doi.org/10.1093/brain/awx081.CrossRefPubMedGoogle Scholar
  17. 17.
    Laezza F, Lampert A, Kozel MA, Gerber BR, Rush AM, Nerbonne JM, et al. FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. Mol Cell Neurosci. 2009;42:90–101.  https://doi.org/10.1016/j.mcn.2009.05.007.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Laezza F, Gerber BR, Lou JY, Kozel MA, Hartman H, Craig AM, et al. The FGF14(F145S) mutation disrupts the interaction of FGF14 with voltage-gated Na+ channels and impairs neuronal excitability. J Neurosci. 2007;27:12033–44.  https://doi.org/10.1523/JNEUROSCI.2282-07.2007.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of NeurologyUniversity Hospital ZurichZurichSwitzerland
  2. 2.Division of Human Genetics, Department of PediatricsUniversity Hospital BerneBerneSwitzerland
  3. 3.University of ZurichZurichSwitzerland

Personalised recommendations